Incyte (INCY) Net Margin (2010 - 2026)

Incyte (INCY) reported Net Margin of 23.83% for Q1 2026, up 881.0% on a YoY basis from 2.43% in Q1 2025, and up 20.0% quarter-over-quarter from 19.86% in Q4 2025.

Incyte (INCY) Net Margin (2010 - 2026) Analysis & Trends

Incyte has reported Net Margin for 17 years, with the latest figure at 23.83% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 881.0% year-over-year to 23.83%; the trailing twelve-month figure through Mar 2026 stood at 26.71% (up 2623.0% YoY), and the FY2025 full-year result was 25.03%, up 2426.0% from the prior year.
  • Net Margin for Q1 2026 stood at 23.83%, up from 19.86% in the prior quarter.
  • The five-year high for Net Margin was 33.32% in Q2 2025, with the low at 42.6% in Q2 2024.
  • Historically, Net Margin has averaged 13.43% across 5 years, with a median of 17.71% in 2022.
  • Annual changes were most pronounced in 2024 — Net Margin plunged 6392 bps — and 2025, when it soared 7591 bps.
  • Incyte's Net Margin stood at 3.07% in 2022, then surged by 546 bps to 19.84% in 2023, then fell by 14 bps to 17.07% in 2024, then rose by 16 bps to 19.86% in 2025, then increased by 20 bps to 23.83% in 2026.
  • The last three Net Margin figures came in at 23.83% (Q1 2026), 19.86% (Q4 2025), and 31.05% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 23.83%

Historic Data

Download Data
DateValue
Mar 31, 2026 23.83%
Dec 31, 2025 19.86%
Sep 30, 2025 31.05%
Jun 30, 2025 33.32%
Mar 31, 2025 15.03%
Dec 31, 2024 17.07%
Sep 30, 2024 9.36%
Jun 30, 2024 -42.60%
Mar 31, 2024 19.25%
Dec 31, 2023 19.84%
Sep 30, 2023 18.64%
Jun 30, 2023 21.32%
Mar 31, 2023 2.68%
Dec 31, 2022 3.07%
Sep 30, 2022 13.70%
Jun 30, 2022 17.71%
Mar 31, 2022 5.18%
Dec 31, 2021 65.35%
Sep 30, 2021 22.35%
Jun 30, 2021 21.18%